Fibromyalgia: pathogenetic, diagnostic and therapeutic concerns.
Musculoskeletal pains are one of the most common complaints reported by patients. In 1972, Smythe described the generalized pain and tenderness on palpation at specific points and, 4 years later, the term fibromyalgia was introduced for determining the disease syndrome. The etiology and pathogenesis of fibromyalgia are still unknown. This disease appears probably multi-factorial. It is considered that the changes in the neuronal activity in the central nervous system, abnormal metabolism of biogenic amines and immunological disorders may among other things, contribute to the development of the disease. The complaints are non characteristic and highly sujective, which makes it substantially difficult to differentiate between fibromialgia and both chronic fatigue syndrome and psychosomatic diseases. The treatment of fibromyalgia is complex and long-term. The antidepressants and psychotherapy is of vital importance. The effectiveness of locally used agents is also being emphasized. Fibromyalgia has become a serious social problem in the well developed countries in the recent years. Therefore, of importance are efforts to appropriately diagnose fibromyalgia and to implement its appropriate treatment that resolves disease symptoms in a possibly maximum degree.
Podolecki
Tomasz
T
Independent Public Central Clinical Hospital, Katowice, Poland. tomekpod@interia.pl
Podolecki
Andrzej
A
Hrycek
Antoni
A
D003937:Diagnosis, Differential; D005060:Europe / Q000453:epidemiology; D015673:Fatigue Syndrome, Chronic / Q000175:diagnosis; D005356:Fibromyalgia / Q000175:diagnosis* / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D006801:Humans; D015994:Incidence; D011602:Psychophysiologic Disorders / Q000175:diagnosis; D011788:Quality of Life; D014481:United States / Q000453:epidemiology